NCT00003220View on ClinicalTrials.gov

Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

February 28, 1998

Primary Completion Date

November 30, 2000

Study Completion Date

June 30, 2001

Conditions
Colorectal Cancer
Interventions
DRUG

bryostatin 1

Trial Locations (2)

48201

Barbara Ann Karmanos Cancer Institute, Detroit

48201-1932

Veterans Affairs Medical Center - Detroit, Detroit

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Barbara Ann Karmanos Cancer Institute

OTHER

NCT00003220 - Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter